55800
49827
S&P/TSX
16144.79
-17.52
(-0.11%)
S&P-CDNX
787.85
+1.46
(0.19%)
S&P-500
2724.44
-8.57
(-0.31%)
NASDAQ
7378.46
-15.58
(-0.21%)
Dow
24834.41
-178.88
(-0.72%)
Dollar
0.78014
-0.00013
(-0.01717%)
Oil
72.17
-0.03
(-0.04%)
Gold
1292.40
+0.40
(+0.03%)
Silver
16.580
+0.005
(+0.03%)


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

54886
Data from CryptoCompare
Recent Trending
Okanagan Oldies
55849
Castanet Proud Member of RTNDA Canada
54234
Press Room
49335
55504